-
10881“…We performed a phenotypic analysis of DPT cells in blood and liver from patients chronically infected by hepatitis C (HCV) or B (HBV) viruses. The highest percentages of DPT cells, predominantly CD4(high)CD8(low), were observed in patients infected by HCV, while HBV-infected patients mostly displayed CD4(low)CD8(high) and CD4(high)CD8(high) DPT cells. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso
Texto -
10882“…BACKGROUND & OBJECTIVES: Hepatitis C virus (HCV) has emerged as a leading cause of chronic hepatitis, liver cirrhosis and hepatocellular carcinoma worldwide. …”
Enlace del recurso
Enlace del recurso
Texto -
10883por Nishikawa, Hiroki, Inuzuka, Tadashi, Takeda, Haruhiko, Nakajima, Jun, Sakamoto, Azusa, Henmi, Sinichiro, Ishikawa, Tetsurou, Saito, Sumio, Kita, Ryuichi, Kimura, Toru, Osaki, Yukio, Koshikawa, Yorimitsu“…A 66-year-old man with advanced hepatitis C virus-related HCC with PVTT in the right lobe of the liver was treated with TAI with epirubicin suspended in iodized oil; however, tumor marker levels (alpha-fetoprotein and des-gamma-carboxy protein) did not decrease. …”
Publicado 2010
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
10884“…Recent progress in defining the molecular mechanisms of Hepatitis C Virus (HCV) entry affords the opportunity to exploit new viral and host targets for therapeutic intervention. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
10885por Scheele, Jürgen S, Harder, Jan, Stankovic, Zoran, Räpple, Daniel, Dorn, Annette, Spangenberg, Hans C, Blum, Hubert E“…CASE PRESENTATION: Here, we report the case of a 78-year-old Caucasian male patient who presented with multifocal hepatocellular carcinoma and chronic hepatitis C virus infection. Over a four-year period our patient was treated with radiofrequency ablation and transarterial chemoembolization. …”
Publicado 2011
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
10886por Sung, Pil Soo, Choi, Hee Baeg, Kim, Su-Yeon, Hong, Sung Woo, Park, Chung-Hwa, Song, Myeong Jun, Lee, Sung Won, Yoo, Chan Ran, Choi, Sang Wook, Han, Nam Ik, Kim, Tai-Gyu, Yoon, Seung Kew“…Natural killer (NK) cells play an important role in innate immunity, especially in the response to viral infections, such as hepatitis C virus (HCV). Killer cell immunoglobulin-like receptors (KIRs) are the primary receptors of NK cells that mediate innate immunity. …”
Publicado 2011
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
10887por Marra, Monica, Sordelli, Ignazio M, Lombardi, Angela, Lamberti, Monica, Tarantino, Luciano, Giudice, Aldo, Stiuso, Paola, Abbruzzese, Alberto, Sperlongano, Rossella, Accardo, Marina, Agresti, Massimo, Caraglia, Michele, Sperlongano, Pasquale“…The major etiological factors for HCC are both hepatitis B virus (HBV) and hepatitis C virus infection (HCV). Continuous oxidative stress, which results from the generation of reactive oxygen species (ROS) by environmental factors or cellular mitochondrial dysfunction, has recently been associated with hepatocarcinogenesis. …”
Publicado 2011
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
10888por Veselkin, Elena, Kondratyev, Maria, Lurie, Yoav, Ron, Efrat, Santo, Moshe, Reif, Shimon, Elashvili, Irma, Bar, Lana, Lederkremer, Gerardo Z.“…We compared blindly pretreatment serum samples from a cohort of 44 hepatitis C patients, which had METAVIR-scored biopsies, with 28 healthy individuals. …”
Publicado 2011
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
10889por Yu, Xuelian, Zhang, Jing, Hong, Liang, Wang, Jiayu, Yuan, Zhengan, Zhang, Xi, Ghildyal, Reena“…Although B19 virus, the best characterized human parvovirus, has been shown to co-infect patients with hepatitis B or hepatitis C virus (HBV, HCV) infection, the association of PARV4 with HBV or HCV infections is still unknown. …”
Publicado 2012
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
10890“…CONTEXT: Patients with end-stage renal disease can easily acquire a hepatitis C virus (HCV) infection via several ways. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
10891por Kalantari, Hamid, Davari, Majid, Akbari, Mojtaba, Hejazi, Seyed Mehdi, Kalantari, Maryam, Zakerin, Shahram, Shahshahan, Zahra“…FINDINGS: The results of this study showed that the total cost of diagnostic services for hepatitis B virus (HBV) and hepatitis C virus (HCV) patients, with state medical tariffs, was US$ 1499.07 and US$ 2084.89, respectively. …”
Publicado 2012
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
10892por Kikuma, Kanta, Watanabe, Jiro, Oshiro, Yumi, Shimogama, Tatsuo, Honda, Yumi, Okamura, Seiichi, Higaki, Koichi, Uike, Naokuni, Soda, Tetsuro, Momosaki, Seiya, Yokota, Tadaaki, Toyoshima, Satoshi, Takeshita, Morishige“…Eight of the 12 DLBCL cases (66.7%) and two of the eight MALT lymphoma cases (25%) had serum anti-hepatitis C virus (HCV) antibodies and HCV RNA. The incidence of HCV infection was significantly higher in the hepatic DLBCL cases than in systemic intravascular large B-cell cases with liver involvement (one of 11 cases, 9.1%) and T/NK-cell lymphoma cases (one of 19 cases, 5.3%) (p < 0.01 for both). …”
Publicado 2012
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
10893“…NS5B is the RNA-dependent RNA polymerase responsible for replicating hepatitis C virus (HCV) genomic RNA. Despite more than a decade of work, the formation of a highly active NS5B polymerase·RNA complex suitable for mechanistic and structural studies has remained elusive. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
10894por Liu, Man-Qing, Zhou, Dun-Jin, Wang, Xu, Zhou, Wang, Ye, Li, Li, Jie-Liang, Wang, Yi-Zhong, Ho, Wen-Zhe“…BACKGROUND: Interferon lambda 3 (IFN-λ3) is a newly identified cytokine with antiviral activity, and its single nucleotide polymorphisms are strongly associated with the treatment effectiveness and development of chronic hepatitis C virus infection. We thus examined the potential of IFN-λ3 to inhibit HIV replication and the possible mechanisms of the anti-HIV action by IFN-λ3 in human macrophages. …”
Publicado 2012
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
10895por Khan, Ihsan, Vasudevan, Viswanath, Nallagatla, Sasikanath, Arjomand, Farhad, Ali, Rana“…We report a patient with inoperable HCC with underlying Hepatitis C and liver cirrhosis, who developed acute lung injury following targeted chemoembolization of selective feeding hepatic artery with LC beads loaded with doxorubicin. …”
Publicado 2012
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
10896“…In this article, we reviewed studies performed in Mongolia from 2000 to 2011 on seroprevalence of hepatitis B virus (HBV) and hepatitis C virus (HCV) among healthy individuals and patients with chronic liver diseases, and on the practice patterns for the management of liver cirrhosis and hepatocellular carcinoma (HCC). …”
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
10897por Giovanna Brunasso, Alexandra Maria, Michetti, Paolo, Fancelli, Laura, Massone, Cesare“…BACKGROUND: Treatment of psoriasis in the setting of chronic hepatitis C virus (HCV) infection is difficult, because standard therapies like methotrexate are associated with increased hepatic toxicity. …”
Publicado 2012
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
10898por Huang, Jing-Ying, Su, Wen-Chi, Jeng, King-Song, Chang, Tien-Hsien, Lai, Michael M. C.“…For Hepatitis C virus (HCV), initiation of translation is cap-independently mediated by its internal ribosome entry site (IRES). …”
Publicado 2012
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
10899por Rönsholt, Frederikke Falkencrone, Ostrowski, Sisse Rye, Katzenstein, Terese Lea, Ullum, Henrik, Gerstoft, Jan“…Higher levels of CD8 memory T cells (CD8+,CD45RO+,CD45RA-) showed a significant beneficiary effect on survival, HR of 0.95 (95% confidence interval 0.91–0.99, P = 0.016) when adjusted for age, nadir CD4 count, CD4 count, and AIDS and hepatitis C status. T cell activation was not associated with increased risk of death. …”
Publicado 2012
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
10900por Ohno, Zentaro, Tamaki, Hidetoshi, Ohsuga, Takeshi, Iwata, Hiroyuki, Yasuda, Norio, Mori, Yoshio“…CASE PRESENTATION: Case 1 was a 71-year-old woman who was treated at our hospital for chronic hepatitis C, nontuberculous mycobacteria infection, and bronchiectasis. …”
Publicado 2012
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto